New treatment in breast cancer metastatic and pretreated

被引：0
作者：
Di Cristina, L
Cirrito, D
Vitello, S
机构：
[1] Serv Oncol, Alcamo, TP, Italy
[2] Osped S Elia Caltanissetta, Serv Oncol, Caltanissetta, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E26
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
[21]   Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer [J].
Onyenadum, A. ;
Gogas, H. ;
Kosmidis, P. ;
Aravantinos, G. ;
Bafaloukos, D. ;
Bacoyiannis, H. ;
Markopoulos, C. ;
Koutras, A. ;
Tzorakoelefterakis, E. ;
Makatsoris, T. ;
Fountzilas, G. ;
Kalofonos, H. P. .
JOURNAL OF CHEMOTHERAPY, 2006, 18 (02) :192-198
[22]   What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer? - Reply [J].
Keller, AM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :6261-6261
[23]   Everolimus in combination with carboplatin: a promising treatment with low toxicity in heavily pretreated metastatic breast cancer [J].
Schwarzlose-Schwarck, S. ;
Regierer, A. C. ;
Martus, P. ;
Schulz, C. -O. ;
Liu, H. ;
Schefe, J. H. ;
Possinger, K. ;
Scholz, C. W. ;
Eucker, J. .
ONKOLOGIE, 2011, 34 :118-118
[24]   The Palliative CMF is a Reasonable Salvage Treatment Option in Heavily Pretreated Patients With Metastatic Breast Cancer [J].
Park, J. ;
Lim, Y. ;
Lee, K. H. ;
Han, S. W. ;
Oh, D. Y. ;
Im, S. A. ;
Kim, T. Y. ;
Bang, Y. J. .
EUROPEAN JOURNAL OF CANCER, 2011, 47 :S346-S346
[25]   Single-agent capecitabine: A reference treatment for taxane-pretreated metastatic breast cancer? [J].
Seidman, AD ;
O'Shaughnessy, J ;
Misset, JL .
ONCOLOGIST, 2002, 7 :20-28
[26]   Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer [J].
Laessig, D. ;
Stemmler, H. J. ;
Vehling-Kaiser, U. ;
Fasching, P. A. ;
Melchert, F. ;
Koelbl, H. ;
Stauch, M. ;
Maubach, P. ;
Scharl, A. ;
Morack, G. ;
Meerpohl, H. ;
Weber, B. ;
Kalischefski, B. ;
Heinemann, V. .
ONCOLOGY, 2007, 73 (5-6) :407-414
[27]   Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer [J].
Onyenadum, A. ;
Gogas, H. ;
Markopoulos, C. ;
Bafaloukos, D. ;
Aravantinos, G. ;
Mantzourani, M. ;
Koutras, A. ;
Tzorakoelefterakis, E. ;
Xiros, N. ;
Makatsoris, T. ;
Fountzilas, G. ;
Kalofonos, H. P. .
JOURNAL OF CHEMOTHERAPY, 2007, 19 (05) :582-589
[28]   A new HER2-targeted therapeutic option for pretreated patients with metastatic breast cancer [J].
Banys-Paluchowski, M. .
ONKOLOGE, 2020, 26 (06) :561-563
[29]   Gemcitabine and carboplatin in heavily pretreated metastatic breast cancer: predictive value of breast cancer subtypes [J].
Natoli, G. ;
Nelli, F. ;
Moscetti, L. ;
D'Auria, G. ;
Signorelli, C. ;
Chilelli, M. G. ;
Padalino, D. ;
Massari, A. ;
Ruggeri, E. M. .
EJC SUPPLEMENTS, 2009, 7 (02) :279-279
[30]   Treatment of metastatic breast cancer [J].
Welt, Anja ;
Decker, Thomas ;
Poettgen, Christoph .
ONKOLOGE, 2022, 28 (SUPPL 1) :61-63
12345